DINGDANG HEALTH (09886) spent 32,600 Hong Kong dollars to repurchase 40,000 shares on March 24th.
Dingdang Health (09886) announced that on March 24, 2026, it spent 32,600 Hong Kong dollars to repurchase 40,000 shares.
DINGDANG HEALTH (09886) announced on March 24, 2026, to buy back 40,000 shares at a cost of HKD 32,600.
Related Articles
MBV INTL (01957) has completed the sale of 40% of the issued share capital of Lordan Group Ltd.
.png)
SOUTH CHINA FIN (00619) announced its performance in 2025, with a net loss of 22.839 million Hong Kong dollars, a year-on-year narrowing of 92.26%.
On March 23, BEKE-W (02423) spent $8 million to repurchase 1.5458 million shares.
MBV INTL (01957) has completed the sale of 40% of the issued share capital of Lordan Group Ltd.
SOUTH CHINA FIN (00619) announced its performance in 2025, with a net loss of 22.839 million Hong Kong dollars, a year-on-year narrowing of 92.26%.
On March 23, BEKE-W (02423) spent $8 million to repurchase 1.5458 million shares.
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026
